Encapsulation of Phaseolus lunatus Protein Hydrolysate with Angiotensin-Converting Enzyme Inhibitory Activity

Table 1

2² factorial design used for Phaseolus lunatus hydrolysate encapsulation with flamboyant carboxymethylated gum/alginate and protein encapsulation efficiency.

Treatment	CaCl2 (mM)	pH	Encapsulation efficiency (%)
1	1.0	4	71.7^c
2	3.0	4	67.3^b
3	1.0	10	78.4^d
4	3.0	10	71.8^c
5	2.0	7	53.1^a
6	2.0	7	53.3^a
7	2.0	7	51.8^a
8	2.0	7	52.0^a

Different superscript letters indicate statistical difference (𝑃<0.05).